Axitinib combination therapies versus sunitinib for renal cell carcinoma

被引：0
|
作者：
Stirrups, Robert
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(19)30104-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：E141 / E141
页数：1
相关论文
共 50 条
  • [41] An evaluation of abemaciclib activity in combination with sunitinib in renal cell carcinoma.
    Holder, Sheldon L.
    Small, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [42] Dose adjustment of axitinib based on AUC in sunitinib-pretreated metastatic renal cell carcinoma.
    Miura, Yuji
    Imamura, Chiyo K.
    Uchino, Keita
    Kishida, Takeshi
    Matsubara, Nobuaki
    Shinojima, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [43] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma.
    Herrmann, E.
    Marschner, N.
    Grimm, M.
    Ohlmann, C. H.
    Hutzschenreuther, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Steiner, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
    Stenner, Frank
    Chastonay, Rahel
    Liewen, Heike
    Haile, Sarah R.
    Cathomas, Richard
    Rothermundt, Christian
    Siciliano, Raffaele D.
    Stoll, Susanna
    Knuth, Alexander
    Buchler, Tomas
    Porta, Camillo
    Renner, Christoph
    Samaras, Panagiotis
    ONCOLOGY, 2012, 82 (06) : 333 - 340
  • [45] Cost-effectiveness and budget impact of pembrolizumab plus axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
    Xander, Nicolas S. H.
    Fiets, W. Edward
    Uyl-de Groot, Carin A.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Sunitinib versus everolimus for non-clear-cell renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 124 - 124
  • [47] Subgroup analysis from JAVELIN Renal 101: Outcomes for avelumab plus axitinib (A plus Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).
    Choueiri, Toni K.
    Motzer, Robert J.
    Campbell, Matthew T.
    Alekseev, Boris Y.
    Uemura, Motohide
    Kollmannsberger, Christian K.
    Gravis, Gwenaelle
    Bjarnason, Georg A.
    Gurney, Howard
    Chung, Jinsoo
    Haanen, John B. A. G.
    Rini, Brian I.
    Larkin, James M. G.
    Schmidinger, Manuela
    Nole, Franco
    Chudnovsky, Aleksander
    Huang, Bo
    Hariharan, Subramanian
    di Pietro, Alessandra
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [48] Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
    David F. McDermott
    Mahrukh A. Huseni
    Michael B. Atkins
    Robert J. Motzer
    Brian I. Rini
    Bernard Escudier
    Lawrence Fong
    Richard W. Joseph
    Sumanta K. Pal
    James A. Reeves
    Mario Sznol
    John Hainsworth
    W. Kimryn Rathmell
    Walter M. Stadler
    Thomas Hutson
    Martin E. Gore
    Alain Ravaud
    Sergio Bracarda
    Cristina Suárez
    Riccardo Danielli
    Viktor Gruenwald
    Toni K. Choueiri
    Dorothee Nickles
    Suchit Jhunjhunwala
    Elisabeth Piault-Louis
    Alpa Thobhani
    Jiaheng Qiu
    Daniel S. Chen
    Priti S. Hegde
    Christina Schiff
    Gregg D. Fine
    Thomas Powles
    Nature Medicine, 2018, 24 : 749 - 757
  • [49] Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
    McDermott, David F.
    Huseni, Mahrukh A.
    Atkins, Michael B.
    Motzer, Robert J.
    Rini, Brian I.
    Escudier, Bernard
    Fong, Lawrence
    Joseph, Richard W.
    Pal, Sumanta K.
    Reeves, James A.
    Sznol, Mario
    Hainsworth, John
    Rathmell, W. Kimryn
    Stadler, Walter M.
    Hutson, Thomas
    Gore, Martin E.
    Ravaud, Alain
    Bracarda, Sergio
    Suarez, Cristina
    Danielli, Riccardo
    Gruenwald, Viktor
    Choueiri, Toni K.
    Nickles, Dorothee
    Jhunjhunwala, Suchit
    Piault-Louis, Elisabeth
    Thobhani, Alpa
    Qiu, Jiaheng
    Chen, Daniel S.
    Hegde, Priti S.
    Schiff, Christina
    Fine, Gregg D.
    Powles, Thomas
    NATURE MEDICINE, 2018, 24 (06) : 749 - +
  • [50] Re: Pazopanib Versus Sunitinib in Metastatic Renal-cell Carcinoma
    Sun, Maxine
    Quoc-Dien Trinh
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EUROPEAN UROLOGY, 2014, 65 (05) : 1014 - 1015
12345